Publication: Data-driven discovery of movement-linked heterogeneity in neurodegenerative diseases. Nature Machine Intelligence

Authors: Mark Endo, Favour Nerrise, Qingyu Zhao, Edith V Sullivan, Li Fei-Fei, Victor W Henderson, Kilian M Pohl, Kathleen L Poston, Ehsan Adeli Abstract Neurodegenerative diseases manifest different motor and cognitive signs and symptoms that are highly heterogeneous. Parsing these heterogeneities may lead to an improved understanding of underlying disease mechanisms; however current methods are dependent on clinical assessments and somewhat arbitrary choice of behavioral tests. Herein, we present a data-driven subtyping approach using video-captured human motion and brain functional connectivity (FC) from resting-state (rs)-fMRI. We applied our framework to a cohort of individuals at different stages of Parkinson's disease (PD). The process mapped the data to low-dimensional measures by projecting them onto a canonical correlation space that identified three PD subtypes: Subtype I was characterized by motor difficulties and poor visuospatial abilities; Subtype II exhibited difficulties in non-motor…

Continue ReadingPublication: Data-driven discovery of movement-linked heterogeneity in neurodegenerative diseases. Nature Machine Intelligence

Oral Presentation: Alzheimer’s Association International Conference

Title: Automated Physical Performance Battery as a Digital Marker for Alzheimer's Disease and Mild Cognitive ImpairmentPresenter: Ehsan Adeli (PI) Abstract: Historically, screening for incidence of AD-related MCI or conversion from MCI to AD dementia has relied on cognitive, activities of daily living, and brain imaging measures. Limitations of this diagnostic approach include dependency on education and language, time-consuming and costly measures, and long-term monitoring. Emerging studies suggest that non-tremor motor dysfunction in dementias is known to be highly associated with AD biomarkers, with signs of cognitive decline visible in gait and hand movement at various stages of the illness. With the evidence that gait and physical disturbances are early predictors of cognitive impairment and that their trajectories could readily be tracked, we utilize recent advances in computer vision (CV) to quantify mobility in a data-driven…

Continue ReadingOral Presentation: Alzheimer’s Association International Conference

Oral Presentation: Alzheimer’s Association International Conference 2024

Dr. Jennifer Myers presented "An Equitable ML-based Music Intervention for At-risk Older Adults," at the Alzheimer’s Association International Conference (Preconference) in Philadelphia, PA. The presentation was part of the Introduction To The Artificial Intelligence And Technology Collaboratories (AITC) For Aging Research Program Pilot Project Showcase

Continue ReadingOral Presentation: Alzheimer’s Association International Conference 2024

Award: AgeTech Collaborative™ from AARP – AgeTech After Dark: Aging Made Easier Pitch Event Grand Prize Winner

John Ralston and the Neursantys team won the Grand Prize at the AgeTech After Dark pitch competition held in San Francisco on June 11, 2024. Source: @AgeTechCollab X.com Post - June 12, 2024 https://twitter.com/AgeTechCollab/status/1800977836507005201

Continue ReadingAward: AgeTech Collaborative™ from AARP – AgeTech After Dark: Aging Made Easier Pitch Event Grand Prize Winner

Accelerating Balance Recovery Using Adaptive EVS Therapy

John Ralston, Neursantys Inc. VP Nguyen, UMass Amherst This project will develop ML-driven methods to adapt EVS stimulus parameters to each patient’s unique sensory and motor impairment profile to increase the effectiveness of NEURVESTA’s current treatment protocol.

Continue ReadingAccelerating Balance Recovery Using Adaptive EVS Therapy